News > What the New Year may bring for Ozempic's development

What the New Year may bring for Ozempic's development

The Indian Express | 01/01/2025 12:48 PM | Click to read full article

Ozempic and other GLP-1 receptor agonists have dominated the weight loss conversation throughout 2024. Initially developed for managing diabetes, these medications have gained significant traction for their weight loss benefits. Critics have raised concerns about the ethics of off-label use, the affordability gap that makes these drugs inaccessible to many, and the long-term implications of relying on medication over lifestyle adjustments.

-